UNSPSC 51294400: Antidepressant piperazines

Antidepressant drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).

UNSPSC 51294400 Antidepressant piperazines (Class) shows minimal alignment between the code's nominal scope and actual state and local procurement activity. The three most recent opportunities in the dataset—involving naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—do not center on antidepressant piperazines or related psychopharmaceutical agents. The mismatch suggests either that jurisdictions are applying the code inconsistently to broader pharmaceutical procurement, or that antidepressant piperazines themselves rarely feature in standalone state and local solicitations. State and local buyers using this code appear to span health departments, state HHS agencies, and cooperative purchasing alliances; the opportunities named include Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which serves multiple states including Oregon.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The Texas HHS Commission posted an RFI (HHS0017013, April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription programs as market intelligence ahead of formal procurement. MMCAP released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with awards effective July 1, 2026 and a two-year contract term. The code does not show robust or recent activity specifically targeting antidepressant piperazines; pursue only if your firm manufactures or distributes pharmaceuticals broadly and can service multi-state cooperative agreements or regional health authority procurement vehicles.